Organization Overview
Alternative names
benazepril (lotensin) (2004)
bisoprolol (zebeta) (2000)
buprenorphine (2015)
cefprozil (cefzil) (2005)
cilostazol (pletal) (2004)
desvenlafaxine (pristiq) (2015)
diclofenac (voltaren) (1995)
econazole (spectazole) (2002)
entecavir (baraclude) (2017)
epinastine (elestat) (2016)
heparin (liquaemin) (2011)
lisinopril (zestril) (2002)
methimazole (tapazole) (2001)
midodrine (proamatine) (2003)
nabumetone (relafen) (2002)
naratriptan (amerge) (2010)
ondansetron (zofran) (2007)
repaglinide (prandin) (2013)
ribavirin (virazole) (2004)
spironolactone (aldactone) (1980)
tenofovir (viread) (2018)
tizanidine (zanaflex) (2002)
triamterene (dyrenium) (1991)
Breast Neoplasms (Phase 2)
Carcinoid Tumor (Phase 2)
Carcinoma (Phase 2)
Carcinoma, Hepatocellular (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Carcinoma, Ovarian Epithelial (Phase 2)
Carcinoma, Renal Cell (Phase 2)
Endometrial Neoplasms (Phase 2)
Glioblastoma (Phase 2)
Lung Neoplasms (Phase 2)
Metaplasia (Phase 1)
Multiple Myeloma (Phase 2)
Myelodysplastic Syndromes (Phase 1)
Neoplasms (Phase 1)
Neoplasms, Plasma Cell (Phase 2)
Ovarian Neoplasms (Phase 2)
Pancreatic Neoplasms (Phase 2)
Preleukemia (Phase 1)
Primary Myelofibrosis (Phase 1)
Prostatic Neoplasms (Phase 2)
Triple Negative Breast Neoplasms (Phase 2)
